LAMA2 and congenital muscular dystrophy: Significant reductions in the amount of SRF have been observed (Sakuma et al., 2004), namely, 40–50 and 50–65% at 2 and 12 weeks of age, respectively, in merosin-deficient congenital muscular dystrophy.